For a medicine to benefit a patient, scientific innovation alone is not enough.
The product must also successfully move through a regulatory system capable of
evaluating its quality, safety, and efficacy efficiently and rigorously.
In regions consisting of multiple national regulatory authorities, differences in
processes and requirements can create duplication and delays. Regulatory harmonization
offers an opportunity to address these challenges while maintaining appropriate
scientific standards.
The East African Experience
The East African Community Medicines Regulatory Harmonization initiative was established
with the goal of improving access to quality medicines.
A central objective has been to simplify medicine registration and improve the speed
with which applications can be reviewed without compromising the requirement that
approved medicines meet appropriate quality standards.
Joint Assessment
One important development has been the use of joint product assessment.
Instead of requiring completely independent assessments to occur in
isolation across participating countries, a harmonized system can create mechanisms
through which expertise and regulatory work are shared.
This can reduce duplication while strengthening collaboration among
participating authorities.
Common Technical Requirements
Harmonization also benefits from common technical requirements.
When applicants face substantially different formats and expectations in
every jurisdiction, resources are consumed addressing procedural differences rather than
advancing the underlying scientific assessment.
The use of a common technical document can make submission and review more
efficient.
The EAC initiative's adoption of a common technical document and joint assessment
process were identified as important strengths by Dr. Ukwu and her co-authors.
Transparency Builds Trust
Harmonization depends on trust among regulators, governments, manufacturers, healthcare
stakeholders, and the public.
Transparent processes help participating authorities understand how decisions are
reached and help establish confidence that comparable scientific standards are being
applied.
This becomes especially important when one authority or joint group performs work that
other participating countries will rely upon.
Simplify, Streamline and Standardize
One of the broader lessons from regulatory harmonization efforts around the world is the
importance of reducing unnecessary duplication.
Processes should be simplified where possible, streamlined where duplication provides
little additional public health value, and standardized where common requirements can
improve efficiency.
Harmonization does not mean eliminating rigorous regulatory oversight.
It means finding better ways to perform that oversight collectively.
Learning Across Regulatory Systems
Regional initiatives do not need to develop every solution independently.
Experience from mature systems and international harmonization efforts can provide
valuable lessons.
At the same time, emerging initiatives can develop approaches that offer
lessons to established systems.
Regulatory learning should therefore move in both directions.
Building Sustainable Systems
Successful harmonization requires more than technical procedures.
It needs trained regulatory professionals, organizational capacity, political
commitment, clear decision-making processes, appropriate resources, and legal frameworks
capable of supporting regional decisions.
The PLOS authors emphasized that mature harmonized systems take time to
develop and highlighted the importance of establishing a binding legal framework for
long-term sustainability.
The Ultimate Measure Is Patient Access
The success of regulatory harmonization should ultimately be judged by its contribution
to public health.
When scientifically sound regulatory processes become more efficient, patients may gain
earlier access to medicines that meet appropriate standards of quality, safety, and
efficacy.
That is the larger promise of harmonization.
The original PLOS Medicine paper was published in August 2020 and lists Dr.
Ukwu as one of seven equal contributors.
